A synthetic form of this peptide, called Exenatide, was the first incretin analog approved by the US FDA to treat diabetes
Avoid taking more than 6 grams pre-workout higher doses don't add performance benefit and increase GI risk during exercise
Glucagon-like peptide-1 (GLP-1) agonist therapies are increasingly being used for type 2 diabetes and obesity, but evidence now shows they also reduce inflammation across multiple organs through mechanisms related and unrelated to weight-loss-driven metabolic improvements
This stage enhances patient outcomes and loyalty
How Employers Are Managing GLP-1 Coverage Rather than eliminating coverage altogether, many employers are implementing structured management strategies designed to balance access, affordability, and outcomes
Lab work may be recommended before or during semaglutide treatment depending on your medical history, medications, symptoms, and risk factors